Stock Events

Stock Events

Alterola Biotech 

$0.005100
7
-$0.00-0% Thursday 20:00

Statistics

Day High
0.2
Day Low
0.2
52W High
0.2
52W Low
0.0002
Volume
20
Avg. Volume
0
Mkt Cap
7.44M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

31MarExpected
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Q4 2020
-0
-0
-0
-0
Expected EPS
N/A
Actual EPS
-0.0003

Financials

-Profit Margin
Unprofitable
2018
2019
2020
2021
2022
2023
0Revenue
-2.37MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ABTI. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Corbus Pharmaceuticals
CRBP
Mkt Cap161.93M
Corbus Pharmaceuticals focuses on the development and commercialization of novel therapeutics to treat inflammatory and fibrotic diseases, using cannabinoid receptor agonists similar to Alterola's approach.
Tilray Brands
TLRY
Mkt Cap560.6M
Tilray is a global leader in cannabis research, cultivation, processing, and distribution, posing competition to Alterola's ambitions in the cannabinoid market.
Canopy Growth
CGC
Mkt Cap424.16M
Canopy Growth Corporation is a world-leading diversified cannabis and cannabinoid-based consumer product company, competing across several of Alterola's target markets.
Aurora Cannabis
ACB
Mkt Cap175.3M
Aurora Cannabis is engaged in the production and distribution of medical cannabis, directly competing with Alterola Biotech in the cannabinoid product space.
Cronos Group
CRON
Mkt Cap1.05B
Cronos Group is an innovative global cannabinoid company, with operations and products that compete with Alterola Biotech's offerings in the cannabinoid sector.

About

Alterola Biotech, Inc. is a pharmaceutical company dedicated to the research and development of cannabinoid and cannabinoid-like molecules. The firm primarily focuses on pioneering regulated pharmaceutical products for human and animal health, as well as regulated food items. Key activities also include the production of active pharmaceutical ingredients (APIs) and food-grade components. Furthermore, the company emphasizes drug formulation and advanced delivery systems to improve bioavailability, solubility, and overall stability. It operates out of Birkenhead, United Kingdom.
Show more...
CEO
Mr. David John Hitchcock O.B.E.
Employees
1
Country
United States
ISIN
US02152V1035

Listings

OTC Link
US
ABTI

0 Comments

Share your thoughts

FAQ

What is Alterola Biotech stock price today?▼
The current price of ABTI is $0.01 USD — it has decreased by -0% in the past 24 hours. Watch Alterola Biotech stock price performance more closely on the chart.
What is Alterola Biotech stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Alterola Biotech stocks are traded under the ticker ABTI.
Is Alterola Biotech stock price growing?▼
ABTI stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Alterola Biotech has showed a +2,450% increase.
What is Alterola Biotech market cap?▼
Today Alterola Biotech has the market capitalization of 7.44M
What were Alterola Biotech earnings last quarter?▼
ABTI earnings for the last quarter are -0 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Alterola Biotech revenue for the last year?▼
Alterola Biotech revenue for the last year amounts to 0 USD.
What is Alterola Biotech net income for the last year?▼
ABTI net income for the last year is -2.37M USD.
How many employees does Alterola Biotech have?▼
As of July 05, 2026, the company has 1 employees.
In which sector is Alterola Biotech located?▼
Alterola Biotech operates in the Health & Wellness sector.
When did Alterola Biotech complete a stock split?▼
The last stock split for Alterola Biotech was on August 26, 2010 with a ratio of 10:1.
Where is Alterola Biotech headquartered?▼
Alterola Biotech is headquartered in Birkenhead, United States.